Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo

Blood

Volumn 103, Issue 2, 2004, Pages 601-606

  Staton, Carolyn A ^a   Brown, Nicola J ^a   Rodgers, Gary R ^a   Corke, Kevin P ^a   Tazzyman, Simon ^a   Underwood, James C E ^a   Lewis, Claire E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHASTATIN; BASIC FIBROBLAST GROWTH FACTOR; FIBRINOGEN; PEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ACTIVATION; CELL DEATH; CELL MIGRATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY; LIVER; LUNG; METASTASIS; PRIORITY JOURNAL; SKIN BLOOD VESSEL; THROMBOSIS;

EID: 0942287729     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-07-2192     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:127-131.
2. Browder T, Folkman J, Pirie-Shepherd S. The haemostatic system as a regulator of angiogenesis. J Biol Chem. 2000;275:1521-1524.
3. Wojtukiewicz MZ, Sierko E, Klement P, Rak, J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3:371-384.
4. van Hinsbergh VW. The endothelium: vascular control of haemostasis. Eur J Obstet Gynecol Reprod Biol. 2001;95:198-201.
5. Nagy JA, Meyers MS, Masse EM, Herzeberg KT, Dvorak HF. Pathogenesis of ascites tumour growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res. 1995;55:369-375.
6. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF. Pathogenesis of ascites tumour growth: angiogenesis, vascular remodelling, and stroma formation in the peritoneal lining. Cancer Res. 1995;55:376-385.
7. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumour growth or angiogenesis, is diminished in fibrinogen deficient mice. Cancer Res. 2002;62:6966-6972.
8. Bootle-Wilbraham CA, Tazzyman S, Marshall JM, Lewis CE. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro. Cancer Res. 2000;60:4719-4724.
9. Brown NJ, Staton CA, Rodgers GR, Corke KP, Underwood JCE, Lewis CE. Fibrinogen E-fragment selectively disrupts the vasculature and inhibits the growth of tumours in a syngeneic murine model. Br J Cancer. 2002;86:1813-1816.
10. Bootle-Wilbraham CA, Tazzyman S, Thompson WD, Stirk CM, Lewis CE. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis. 2001;4:269-275.
11. Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol. 1992;168:47-53.
12. Brown JH, Volkmann N, Jun G, Henschen-Edman AH, Cohen C. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci U S A. 2000;97:85-90.
13. Marsh HC, Meinwald YC, Thannhauser TW, Scheraga HA. Mechanism of action of thrombin on fibrinogen: kinetic evidence for involvement of aspartic acid at position P10. Biochem. 1983;22:4170-4174.
14. Marsh HC, Meinwald YC, Lee S, Martinelli RA, Scheraga HA. Mechanism of action of thrombin on fibrinogen: NMR evidence for a beta bend at or near fibrinogen A alpha Gly (P5)-Gly (P4). Biochemistry. 1985;24:2806-2812.
15. Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999;250:168-173.
16. Liu J, Kolath J, Anderson J, et al. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation. Antisense Nucleic Acid Drug Dev. 1999;9:481-486.
17. Shen J, Ham RG, Karmiol S. Expression of adhesion molecules in cultured human pulmonary microvascular endothelial cells. Microvasc Res. 1995;50:360-372.
18. Grosios K, Holwell SE, McGwon AT, Pettit GR, Bibbby MC. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug. Br J Cancer. 1999;81:1318-1327.
19. Beckstead J. A simple technique for preservation of fixation sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem. 1994;42:1127-1134.
20. Lendrum AC, Fraser DS, Slidders W, Henderson R. Studies on the character and staining of fibrin. J Clin Pathol. 1962;15:401-405.
21. Tozer GM, Bhujwalla ZM, Griffiths JR, Maxwell RJ. Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys. 1989;16:155-164.
22. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996;56:4625-4629.
23. Doolittle RF. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins. Adv Exp Med Biol. 1990;281:25-37.
24. Henschen-Edman AH. On the identification of beneficial and detrimental molecular forms of fibrinogen. Haemostasis. 1999;29:179-186.
25. Maurer MC, Peng JL, An SS, Trosset JY, Henschen-Edman A, Scheraga HA. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin. Biochemistry. 1998;37:5888-5902.
26. Sahni A, Sporn LA, Francis CW. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem. 1999;274:14936-14941.
27. Sahni A, Baker CA, Sporn LA, Francis CW. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation. Thromb Haemost. 2000;83:736-741.
28. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2001;96:3772-3778.
29. Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001;189:197-206.
30. Loike JD, Sodiek B, Cao L, et al. CD11c/CD18 on neutrophils recognises a domain at the N-terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A. 1991;88:1044-1048.